IMMP
Immutep Limited - American Depositary Shares (IMMP)
$95
About Immutep Limited - American Depositary Shares (IMMP)
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Details
Daily high
$3.04
Daily low
$2.93
Price at open
--
52 Week High
$70.60
52 Week Low
$2.93
Market cap
22.1M
Dividend yield
-
Volume
10
Avg. volume
16,477
P/E ratio
-.41
Immutep Limited - American Depositary Shares News
Details
Daily high
$3.04
Daily low
$2.93
Price at open
--
52 Week High
$70.60
52 Week Low
$2.93
Market cap
22.1M
Dividend yield
-
Volume
10
Avg. volume
16,477
P/E ratio
-.41